Trial intelligence / Profile preview

FTD/TPI vs placebo in ctDNA-positive colorectal cancer after curative resection

jRCT2080225267Phase 3Completed

Sponsor
Yoshino Takayuki
Start
Jul 2020
Modality
Small Molecules
01

Overview

Phase 3, randomised, double-blind trial in colorectal cancer (CRC) comparing FTD/TPI (Lonsurf) with Placebo (2 arms). Started Jul 2020; status: completed.

02

Drugs

trifluridine + tipiracil
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on jRCT2080225267.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080225267.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call